Cargando…
Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal-recessive childhood motor neuron disease and the main genetic cause of infant mortality. SMA is caused by deletions or mutations in the survival motor neuron 1 (SMN1) gene, which results in SMN protein deficiency. Only one approved drug has recently beco...
Autores principales: | Ramirez, Agnese, Crisafulli, Sebastiano G., Rizzuti, Mafalda, Bresolin, Nereo, Comi, Giacomo P., Corti, Stefania, Nizzardo, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796116/ https://www.ncbi.nlm.nih.gov/pubmed/29316633 http://dx.doi.org/10.3390/ijms19010167 |
Ejemplares similares
-
Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
por: Bersani, Margherita, et al.
Publicado: (2022) -
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019) -
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014) -
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015) -
iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014)